Merger • Life Science

Naturacare Acquires Hedelab

On June 14, 2021, Naturacare acquired life science company Hedelab

Acquisition Context
  • This is Naturacare’s 1st transaction in the Life Science sector.
  • This is Naturacare’s 1st transaction in Belgium.

Explore All 191 Merger Life Science Deals - Search the Database Free


M&A Deal Summary

Date June 14, 2021
Target Hedelab
Sector Life Science
Buyer(s) Naturacare
Deal Type Merger

Target Company

Hedelab

Ghlin, Belgium
Hedelab is a CDMO with full-service and innovation capability. Hedelab was founded in 1974 and is based in Ghlin, Belgium.
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Naturacare

Montaigu-Vendee, France

Category Company
Sector Packaging
DESCRIPTION

Naturacare is a major player in the formulation, production and packaging of food supplements to improve human and animal health. Naturacare has expertise in more than 1,500 ingredients selected from plants, vitamins, minerals, trace elements, probiotic strains and enzymes, enabling it to offer a wide range of formulations in a variety of forms (capsules, tablets, granules, powders, liquid solutions, chewing gum, etc.). Naturacare is based in Montaigu-Vendee, France.


Deal Context for Buyer #
Overall 1 of 3
Sector: Life Science 1 of 3
Type: Merger 1 of 3
Country: Belgium 1 of 1
Year: 2021 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-05-01 Strapharm

Saint-Hilaire-de-Loulay, France

Strapharm is a contract development and manufacturing company for food supplements. The company supplies major food supplement brands and large retailers in France and internationally. Strapharm covers the full range of food and dietary supplements and has significant expertise in products for supporting immunity, supporting sports performance and the health and vitality of pets. Strapharm was founded in 1987 and is based in France.

Buy -

Explore Related M&A Activity